Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. news
  3. cognition test
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Cognition Test Articles & Analysis

15 news found

Multi-Type Animal Cognitive Behavioral Tests for Disease Research

Multi-Type Animal Cognitive Behavioral Tests for Disease Research

Cognitive behavioral tests have wide applications in understanding neurodegenerative diseases and non-neurological disorders that often lead to cognitive dysfunction. ...

ByProtheragen


Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD

Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD

Although there is no single medical, physical, or genetic test for ADHD, qualified mental health care professionals and physicians can provide a diagnostic evaluation after gathering information from multiple sources, including: ADHD symptom checklists, standardized behavior rating scales, detailed histories of past and current functioning, and information obtained from family ...

ByCingulate


Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update

Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update

Although there is no single medical, physical, or genetic test for ADHD, qualified mental health care professionals and physicians can provide a diagnostic evaluation after gathering information from multiple sources, including: ADHD symptom checklists, standardized behavior rating scales, detailed histories of past and current functioning, and information obtained from family ...

ByCingulate


Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

The Women’s Brain Project, an international non-profit organization studying gender and sex determinants to brain and mental health and Altoida, a precision neurology company pioneering non-invasive brain health diagnostics using AI and augmented reality (AR), today announced results from a study showing sex-based differences using digital biomarker data collected from Altoida’s ...

ByAltoida, Inc.


Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

The Women’s Brain Project, an international non-profit organization studying gender and sex determinants to brain and mental health and Altoida, a precision neurology company pioneering non-invasive brain health diagnostics using AI and augmented reality (AR), today announced results from a study showing sex-based differences using digital biomarker data collected from Altoida’s ...

ByAltoida, Inc.


NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD

NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD

” Building on earlier work at UCLA, this trial is designed to demonstrate the safety and efficacy of eTNS in a larger trial and validate certain hypotheses about the therapy’s mechanism of action, including the possibility of predicting responders with cognitive and EEG tests prior to initiating therapy. Funding for the 4-week blinded period is ...

ByNeuroSigma, Inc.


Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform

Altoida upsizes its Series A Round to $20.3M to Advance Its First in Class AI-Powered Neurocognitive Assessment Platform

Altoida’s technology platform uses artificial intelligence (AI) to analyze cognitive and functional test results and help diagnose neurological diseases, like Mild Cognitive Impairment (MCI) and Alzheimer’s. The proprietary 10-minute set of digital test activities (completed on a smartphone or tablet) use augmented ...

ByAltoida, Inc.


NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to Date

NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to Date

The clinical trial will be led by Professor Katya Rubia, a Professor of Cognitive Neuroscience at King’s IoPPN, and is funded by a £1.9 million award from a partnership between the UK’s National Institute for Health Research (NIHR) and the Medical Research Council (MRC). ...

ByNeuroSigma, Inc.


Altoida Partners With GN Group to Research and Develop New Cognitive Assessment Technology to Detect Mild Cognitive Impairment

Altoida Partners With GN Group to Research and Develop New Cognitive Assessment Technology to Detect Mild Cognitive Impairment

Altoida’s technology uses artificial intelligence (AI) to analyze cognitive test results to help diagnose neurological diseases, like MCI and Alzheimer’s Disease. The proprietary digital test activities use augmented reality (AR) to simulate real-world activities of daily living and can be completed on a smartphone or tablet in under ...

ByAltoida, Inc.


Appointment of Non-Executive Director and additional key hires

Appointment of Non-Executive Director and additional key hires

He was previously a Founder and CEO of Deontics Ltd, an AI clinical decision support technology company spun out from the University of Oxford, University Col-lege London and Cancer Research UK, and was Chairman of Cambridge Cognition Ltd (now Cam-bridge Cognition Holdings PLC (AIM: COG)), a computerised cognitive testing ...

ByManus Neurodynamica


Major Research Findings Highlight Effectiveness of the PrecivityAD™ Blood Test That Clinicians Use to Aid in Alzheimer’s Disease Diagnosis

Major Research Findings Highlight Effectiveness of the PrecivityAD™ Blood Test That Clinicians Use to Aid in Alzheimer’s Disease Diagnosis

Four separate research reports presented at premier Alzheimer’s disease and aging conferences add to the increasing set of details about the accuracy and clinical usefulness of the PrecivityAD™ blood test from C2N Diagnostics. The PrecivityAD™ test is a breakthrough blood test intended for use in patients with ...

ByC2N Diagnostics


JAMA Highlights Success of BrainScope`s EEG-based Concussion Index As Reliable Indicator of Concussion

JAMA Highlights Success of BrainScope`s EEG-based Concussion Index As Reliable Indicator of Concussion

In the study, male and female (age 13-25 years) athletes with concussion and athlete "controls" (without concussion) were assessed through a variety of methods, including EEG, cognitive testing and symptom inventories within 72 hours of the injury, when they returned to play, and 45 days after they returned to play. ...

ByBrainScope Company, Inc.


Novatek’s Cognistat Wins Research Poster Award at 6th National Annual Conference of Indian Association of Clinical Psychologists

Novatek’s Cognistat Wins Research Poster Award at 6th National Annual Conference of Indian Association of Clinical Psychologists

It is with great privilege that we announce that the All India Institute of Medical Sciences, New Delhi (AIIMS) Research Poster on Cultural Adaptation of Cognistat Computerized Cognitive Assessment Test was awarded the best research poster at the 46th National Annual Conference of Indian Association of Clinical Psychologists in Chandigarh, India February 21-23, ...

ByNovatek Medical Data Systems


Novatek to support hope for Dementia Charity Gala Jan. 31, 2019

Novatek to support hope for Dementia Charity Gala Jan. 31, 2019

We are dedicated to supporting the diagnosis, treatment and prevention of dementia and other cognitive disorders. Our first annual charity event is expected to bring community leaders, organizations, and those who are interested in supporting Dementia and Alzheimer’s. ...

ByNovatek International


Computerized Cognition Test Provides Better Assessment than Observation

Computerized Cognition Test Provides Better Assessment than Observation

Research published in the Journal of Alzheimer’s Disease this week suggests healthy older adults are less capable of observing their own cognitive decline over an 18 month period than Cogstate’s computerized brief battery (CBB). The study, conducted by neuropsychologists, also indicated that close family members were unable to perceive decline in the cognitive behavior of their ...

ByIOS Press

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Industry Products
  • Medical Industry Software
  • Medical Industry Training
  • Medical Industry Services
  • Medical Industry Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles
  • Medical Industry Books
  • Medical Industry Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT